drugset / Trial / NCT03688971
Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To explore the efficacy and pharmacodynamic effects of omiganan topical gel in facial seborrheic dermatitis.
Timeline
- Start
- 2018-10-22
- Primary completion
- 2019-12
- Completion
- 2019-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ketoconazole | Small molecule | 2 % | Topical |
| Subject | Omiganan | Protein / enzyme biologic | 1.75 % | Topical |